Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis

Colloids and Surfaces B: Biointerfaces

Volumn 117, Issue , 2014, Pages 216-224

  Saraswathy, Ariya ^a   Nazeer, Shaiju S ^a   Jeevan, Madhumol ^a   Nimi, Nirmala ^a   Arumugam, Sabareeswaran ^a   Harikrishnan, Vijayakumar S ^a   Varma, P R Harikrishna ^a   Jayasree, Ramapurath S ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Citrate; Contrast agents; Magnetic relaxivity; MRI; Stability; Superparamagnetism

Indexed keywords

CONVERGENCE OF NUMERICAL METHODS; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; MAMMALS; METAL NANOPARTICLES; OPTIMIZATION; PARTICLE SIZE; SUPERPARAMAGNETISM; THICKNESS MEASUREMENT;

CELLULAR COMPATIBILITY; CITRATE; CONTRAST AGENT; HISTOPATHOLOGICAL ANALYSIS; IRON OXIDE NANOPARTICLE; RELAXIVITY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SURFACE CHARACTERISTICS;

SYNTHESIS (CHEMICAL);

CITRATE COATED ULTRA ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; CITRIC ACID; FERRIC ION; FERRIC OXIDE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD COMPATIBILITY; CELL INTERACTION; CELL LABELING; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY TEST; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG STABILITY; DRUG SYNTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIVER FIBROSIS; LONGITUDINAL RELAXIVITY; MAGNETIC RELAXIVITY; MALE; NANOBIOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIOLOGICAL PARAMETERS; RAT; THERMOGRAVIMETRY; TRANSVERSE RELAXIVITY; ZETA POTENTIAL; ANIMAL; CELL COMMUNICATION; DIAGNOSTIC USE; DISEASE MODEL; LIVER CIRRHOSIS; PATHOLOGY; REPRODUCIBILITY; THROMBOCYTE AGGREGATION; TUMOR CELL LINE; ULTRASTRUCTURE; WISTAR RAT; X RAY DIFFRACTION;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CITRATES; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; NANOPARTICLES; PARTICLE SIZE; PLATELET AGGREGATION; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84896133327     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.02.034     Document Type: Article

References (45)

1. Santra S., Kaittanis C., Grimm J., et al. Small 2009, 5:1862.
2. Durgadas C.V., Sharma C.P., Sreenivasan K. Nanoscale 2011, 3:4780.
3. Laurent S., Forge D., Port M., et al. Chem. Rev. 2008, 108:2064.
4. Jemal A., Bray F., Center M.M., et al. CA Cancer J. Clin. 2011, 61:69.
5. Kim S.H., Kim E.J., Hou J.H., et al. Biomaterials 2009, 30:959.
6. Kolios G., Valatas V., Kouroumalis E. World J. Gastroenterol. 2006, 12:7413.
7. Gupta A.K., Gupta M. Biomaterials 2005, 26:3995.
8. Yu J.H., Li X.Y., Luo Y., et al. Colloids Surf. B: Biointerfaces 2013, 107:213.
9. Majd M.H., Asgari D., Barar J., et al. Colloids Surf. B: Biointerfaces 2013, 106:117.
10. Saraswathy A., Nazeer S.S., Nimi N., et al. Carbohydr. Polym. 2014, 101:760.
11. Berry C.C., Curtis A.S.G. J. Phys. D: Appl. Phys. 2003, 36:R198.
12. Geraldes C.F.G.C., Laurent S. Contrast Media Mol. Imaging 2009, 4:1.
13. Tong S., Hou S., Zheng Z., et al. Nano Lett. 2010, 10:4607.
14. Kim B.H., Lee N., Kim H., et al. J. Am. Chem. Soc. 2011, 133:12624.
15. Soenen S.J.H., Hodenius M., De Cuyper M. Nanomedicine 2009, 4:177.
16. Srivastava S., Awasthi R., Gajbhiye N.S., et al. J. Colloid Interface Sci. 2011, 359:104.
17. Kotsmar C., Yoon K.Y., Yu H.Y., et al. Ind. Eng. Chem. Res. 2010, 49:12435.
18. Wan J.Q., Jiang X.H., Li H., et al. J. Mater. Chem. 2012, 22:13500.
19. Nidhin M., Nazeer S.S., Jayasree R.S., et al. RSC Adv. 2013, 3:6906.
20. Roongta U.V., Pabalan J.G., Wang X., et al. Mol. Cancer Res. 2011, 9:1551.
21. Bellini M.J., Polo M.P., de Alaniz M.J., et al. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:351.
22. Andreas K., Georgieva R., Ladwig M., et al. Biomaterials 2012, 33:4515.
23. Gnanaprakasam Thankam F., Muthu J., Sankar V., et al. Colloids Surf. B: Biointerfaces 2013, 107:137.
24. Jayalekshmi A.C., Victor S.P., Sharma C.P. Colloids Surf. B: Biointerfaces 2013, 101:196.
25. Constandinou C., Henderson N., Iredale J.P. Methods Mol. Med. 2005, 117:237.
26. Nigam S., Barick K.C., Bahadur D. J. Magn. Magn. Mater. 2011, 323:237.
27. Carp O., Patron L., Culita D.C., et al. J. Therm. Anal. Calorim. 2010, 101:181.
28. Srivastava A., Gunjikar V.G., Sinha A.P.B. Thermochim. Acta 1987, 117:201.
29. Mandal M., Kundu S., Ghosh S.K., et al. J. Colloid Interface Sci. 2005, 286:187.
30. Rocca A.G., Marco J.F., Morales M.P., et al. J. Phys. Chem. C 2007, 111:18577.
31. Jayasree R.S., Bushiri M.J., John A., et al. Spectrochim. Acta A 2006, 64:518.
32. Gupta A.K., Wells S. IEEE Trans. Nanobiosci. 2004, 3:66.
33. Ma H.L., Qi X.T., Maitani Y., et al. Int. J. Pharm. 2007, 333:177.
34. Liu J., Sun Z., Deng Y., et al. Angew. Chem. Int. Ed. 2009, 48:5875.
35. Safi M., Berret J.F. Phys. Proc. 2010, 9:266.
36. Web References. http://www.thefreelibrary.com/AMAG+Pharmaceuticals,+Inc.+Announces+Update+on+Sinerem(TM)+in+Europe.-a0172378541.
37. Soenen S.J., Himmelreich U., Nuytten N., et al. Biomaterials 2011, 32:195.
38. Zhu X.M., Wang Y.X.J., Leung K.C.F., et al. Int. J. Nanomed. 2012, 7:953.
39. Hafelli U.O., Riffle J.S., Harris-Shekhawat L., et al. Mol. Pharm. 2009, 6:1417.
40. Engberink R.D.O., van der Pol S.M.A., Dopp E.A., et al. Radiology 2007, 243:467.
41. Durgadas C.V., Sreenivasan K., Sharma C.P. Biomaterials 2012, 33:6420.
42. Albanese A., Tang P.S., Chan W.C.W. Ann. Rev. Biomed. Eng. 2012, 14:1.
43. Van de Bovenkamp M., Groothuis G.M., Meijer D.K., et al. Toxicol. In Vitro 2007, 21:545.
44. Verma A., Stellacci F. Small 2010, 6:12.
45. Le Naour F., Sandt C., Peng C.Y., et al. Anal. Chem. 2012, 84:10260.